Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.

The Journal of rheumatology - 1 Aug 2014

Mouterde Gaël, Lukas Cédric, Goupille Philippe, Flipo René-Marc, Rincheval Nathalie, Daurès Jean-Pierre, Combe Bernard

Abstract excerpt

OBJECTIVE: To compare the initial clinical, biological, and radiographic findings of early arthritis by positivity for rheumatoid factor (RF) and/or anticyclic citrullinated peptide antibodies (anti-CCP), and to validate a patient profile based on this serologic information. METHODS: The ESPOIR cohort comprises patients presenting synovitis of at least 2 joints for 6 weeks to 6 months. Patients underwent testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anti-Idiotypic
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood Sedimentation

Share to Early Diagnosis

Share to France

Share to Peptides, Cyclic

Share to Rheumatoid Factor

Share to Synovitis

Source

Identifiers

PMID: 25028372
DOI: 10.3899/jrheum.130884

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.PMID 25028372Read ↗

Should anti-citrullinated protein antibody and rheumatoid factor status be reassessed during the first year of followup in recent-onset arthritis? A longitudinal study.Semantic proximity Read ↗

Anti-Carbamylated Protein Antibody Identifies Seronegative Early Rheumatoid Arthritis Missed by Anti-CCP, Independently Predicts Joint Deformity, and Extends ACR/EULAR Classification: A Dose-Response and Bootstrap-Validated Cross-Sectional Study from North IndiaSemantic proximity Read ↗

Anticyclic citrullinated peptide antibody-negative rheumatoid arthritis: clues to disease pathogenesis.Semantic proximity Read ↗

Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.Semantic proximity Read ↗

Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis.Semantic proximity Read ↗

Synovial Immunophenotype and Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiologic Prognosis.Semantic proximity Read ↗

Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting.Semantic proximity Read ↗

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.Semantic proximity Read ↗

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Semantic proximity Read ↗

Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.Semantic proximity Read ↗

Evaluation of the clinical performance of anti-mutated citrullinated vimentin antibody and 14-3-3 eta testing in rheumatoid arthritis.Semantic proximity Read ↗

Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.